Nathanael Lentz
SlowingNamed in filings at Osage Venture PartnersOn the current fund
- Board seats filed
- 11
Named in filings at Osage Venture PartnersOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Strategikon Pharma | Not yet classified | May 2025 | None on file |
| Curavit Clinical Research | Not yet classified | September 2022 | None on file |
| DeepSurface Security | Not yet classified | January 2022 | None on file |
| Noodle Partners | Not yet classified | June 2019 | None on file |
| SEMANTIC AI | Not yet classified | November 2017 | None on file |
| RiskLens | Not yet classified | May 2017 | None on file |
| Wylei | Not yet classified | June 2016 | None on file |
| Pneuron | Not yet classified | May 2015 | None on file |
| RackWare | Enterprise software | June 2014 | Signal Peak Ventures |
| PeopleLinx | Sales & marketing tech | June 2014 | None on file |
| Sidecar Interactive | Sales & marketing tech | January 2014 | Harbert Growth Partners |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The category is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Categories of companies where filings name Nathanael Lentz on the board, based on 3 filed seats with a verified or cited source.
8 more filed seats not yet classified, left out of the shares above.